Kendall Keith J 4
4 · Aquestive Therapeutics, Inc. · Filed Mar 14, 2022
Insider Transaction Report
Form 4
Kendall Keith J
DirectorCEO and President
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2022-03-10+375,000→ 375,000 totalExercise: $2.55Exp: 2032-03-10→ Common Stock (375,000 underlying)
Footnotes (1)
- [F1]The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.